FOMAT Medical Research is testing an antibody cocktail called REGN-COV2, which has been gaining attention nationally as a possible thanks to treat and forestall the infection.
“It’s considerably looking very promising,” said Nicholas Focil, CEO at FOMAT. “It gives your body the tools to fight it off on its own in away.”
People who have an interest in participating within the trials can get free coronavirus testing at a site across from the Oxnard Main Library. Results are returned within an hour. Anyone who tests positive can participate in the trial for treatment.
“This medication is for early-onset,” Focil said. “You are randomized into one in every of three arms. It’s a mix therapy that you just are in high dose, low dose, or placebo. It’s a one-time treatment. So you’ll get treated that very same day and for the subsequent 35 days. You’ll be followed up with about 15 times.”
Anyone who tests negative can qualify for the second study, which is designed for healthy people who are at high risk of infection. They will be given the medicine and will be monitored for 7 months to see if the infection is prevented.
“This one depends on if you’re in a very household with somebody that has COVID,” Focil said. “So what’s important with vaccines and preventative trials, in general, is that you just have high exposure to the disease.”
Focil said the funding for the trials comes from the federal government’s “Operation Warp Speed” project. Its goal is to deliver safe and effective COVID-19 vaccines by January 2021.
COVID-19 Prevention Network lists the following different stages of clinical studies to test preventive vaccines and antibodies against COVID-19:
You must be 18 years or older to participate IN COVID-19 Prevention Trial.